e-NIOS is a partner of the “INNOCENT” consortium (Slovakia, Greece, Norway, Spain, Latvia, ), funded by a EuroNanoMed II ERA-NET grant, aiming at the development of innovative multifunctional nanopharmaceuticals for breast cancer treatment, with emphasis on cancer stem cells.
e-NIOS will be joining IPEM 2017 (www.ipem-market.com) at Palais des Festivals, Cannes, France, 25-27 January, as a part of the Greek delegation of innovative companies selected by EASME.
The Horizon 2020 proposal “INSPIRED”, with the participation of e-NIOS, has been approved for funding. The INSPIRED consortium is an international interdisciplinary network (Greece, Ireland, France, Germany, Chile, USA) with complementary expertise in molecular biology, medicinal chemistry, clinical disease, cell biology, bioinformatics and ‘omics’ technologies, with the objective to develop novel approaches for treatment of cancer and neurodegenerative diseases, by targeting the Endoplasmic Reticulum stress response mechanism.
Facebook page of the project: